ID
30832
Beschreibung
Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin This form is to be completed every 6 months once the patient has entered long-term follow-up.
Stichworte
Versionen (1)
- 25.06.18 25.06.18 -
Rechteinhaber
see clinicaltrials.gov
Hochgeladen am
25. Juni 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Long-Term Follow-Up for Survival & Disease Status
- StudyEvent: ODM
Beschreibung
Additional therapy for NHL since the last LTFU
Alias
- UMLS CUI-1
- C0024305
- UMLS CUI-2
- C1706712
Beschreibung
additional therapy for NHL
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0024305
- UMLS CUI [1,2]
- C1706712
Beschreibung
Lymphoma, Non-Hodgkin Therapeutic procedure Following Visit
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0024305
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0332282
- UMLS CUI [1,4]
- C0545082
Beschreibung
Start Date, Lymphoma, Non-Hodgkin, Therapeutic procedure
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0024305
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0808070
Beschreibung
End date, Lymphoma, Non-Hodgkin, Therapeutic procedure
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0024305
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0806020
Beschreibung
chemotherapeutics regimen total number of cycles ordered, Lymphoma, Non-Hodgkin, Therapeutic procedure
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2045831
- UMLS CUI [1,2]
- C0024305
Beschreibung
Myelodysplasia
Alias
- UMLS CUI-1
- C0026985
Beschreibung
Myelodysplasia diagnosis
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0026985
- UMLS CUI [1,2]
- C0011900
Beschreibung
Myelodysplasia Date of diagnosis
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0026985
- UMLS CUI [1,2]
- C2316983
Beschreibung
AML
Alias
- UMLS CUI-1
- C0023467
Beschreibung
Another malignancy
Alias
- UMLS CUI-1
- C0006826
Beschreibung
TSH measurement
Alias
- UMLS CUI-1
- C0202230
Beschreibung
TSH measurement Date
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0202230
- UMLS CUI [1,2]
- C0011008
Beschreibung
TSH measurement Result
Datentyp
float
Maßeinheiten
- µIU/mL
Alias
- UMLS CUI [1,1]
- C0202230
- UMLS CUI [1,2]
- C1254595
Beschreibung
TSH measurement Not done
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0202230
- UMLS CUI [1,2]
- C1272696
Beschreibung
HAMA
Alias
- UMLS CUI-1
- C1291910
Ähnliche Modelle
Long-Term Follow-Up for Survival & Disease Status
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C1706712 (UMLS CUI-2)
C1706712 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C0332282 (UMLS CUI [1,3])
C0545082 (UMLS CUI [1,4])
C0087111 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
C0024305 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C2316983 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1254595 (UMLS CUI [1,2])
C1272696 (UMLS CUI [1,2])
C3872643 (UMLS CUI [1,2])
C1510755 (UMLS CUI [1,2])
Keine Kommentare